Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAPA: Ceftriaxone vs Cefazolin for Prophylaxis in Shoulder Surgery
NCT02996656Recruiting
- Sponsor
- Université de Montréal
- Start
- Dec 2016
- Primary completion
- Dec 2026
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, double-blind trial of ceftriaxone in Propionibacterium infection (2 arms), sponsored by Université de Montréal. Primary endpoint: Skin Biopsy. Started Dec 2016; status: recruiting.
02
Drugs
ceftriaxone
03
Conditions
Propionibacterium infection
Beyond the preview
Go deeper on NCT02996656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02996656.